RA Capital Management »

Tourmaline Bio shares owned by RA Capital Management

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by RA Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $65M 2.5M 25.71
2024-06-30 $33M 2.5M 12.86

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Vaxcyte SH (PCVX)
Janux Therapeutics SH (JANX)
Legend Biotech Corp- SH (LEGN)
Rhythm Pharmaceuticals SH (RYTM)
Avidity Biosciences SH (RNA)
Tyra Biosciences SH (TYRA)
Evolent Health Inc - A SH (EVH)
Edgewise Therapeutics SH (EWTX)
Biogen SH (BIIB)
Dyne Therapeutics SH (DYN)
Rxsight SH (RXST)
Bicara Therapeutics SH (BCAX)
Climb Bio SH (CLYM)
Ars Pharmaceuticals SH (SPRY)

View all positions for RA Capital Management

Top funds holding Tourmaline Bio

RA Capital Management
venBio Select Advisor
BlackRock
Blue Owl Capital Holdings
TCG Crossover Management
Vanguard Group
Jennison Associates
Qiming U.S. Ventures Management
Rtw Investments
QVT Financial
Nantahala Capital Management
Vivo Capital
Millennium Management
Geode Capital Management
Citadel Advisors

View all funds holding Tourmaline Bio